Litcius/Paper detail

Cyclophilin D: Guardian or Executioner for Tumor Cells?

Ling Zhang, Yi Liu, Rou Zhou, Baoyu He, Wenjun Wang, Bin Zhang

2022Frontiers in Oncology17 citationsDOIOpen Access PDF

Abstract

Cyclophilin D (CypD) is a peptide-proline cis-trans isomerase (PPIase) distributed in the mitochondrial matrix. CypD regulates the opening of the mitochondrial permeability conversion pore (mPTP) and mitochondrial bioenergetics through PPIase activity or interaction with multiple binding partners in mitochondria. CypD initially attracted attention due to its regulation of mPTP overopening-mediated cell death. However, recent studies on the effects of CypD on tumors have shown conflicting results. Although CypD has been proven to promote the aerobic glycolysis in tumor cells, its regulation of malignant characteristics such as the survival, invasion and drug resistance of tumor cells remains controversial. Here, we elaborate the main biological functions of CypD and its relationships with tumor progression identified in recent years, focusing on the dual role of CypD in tumors.

Topics & Concepts

MPTPMitochondrionMitochondrial permeability transition poreBioenergeticsMitochondrial matrixCell biologyAnaerobic glycolysisProgrammed cell deathBiologyChemistryCancer researchGlycolysisBiochemistryApoptosisMetabolismEnzymeNeuroscienceCytosolDopamineDopaminergicSignaling Pathways in DiseaseFOXO transcription factor regulationHistone Deacetylase Inhibitors Research
Cyclophilin D: Guardian or Executioner for Tumor Cells? | Litcius